• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弹性成像技术,一种用于评估高级别浆液性卵巢癌患者新辅助化疗的敏感工具。

Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma.

作者信息

Xie Meng, Zhang Xuyin, Jia Zhan, Ren Yunyun, Wang Wenping

机构信息

Department of Ultrasound, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200090, P.R. China.

Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200090, P.R. China.

出版信息

Oncol Lett. 2014 Oct;8(4):1652-1656. doi: 10.3892/ol.2014.2346. Epub 2014 Jul 11.

DOI:10.3892/ol.2014.2346
PMID:25202385
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4156260/
Abstract

The aim of the present study was to evaluate tumor stiffness by ultrasound elastography, which has the potential to provide additional information that is useful in predicting the response to neoadjuvant chemotherapy (NACT) in high-grade serous ovarian carcinoma (HGSC) patients. In total, 32 patients with International Federation of Gynecology and Obstetrics stage III and IV epithelial ovarian cancer treated with NACT underwent transvaginal and transabdominal sonography, followed by elastography and finally, by interval cytoreductive surgery. Histopathological analysis revealed 24 (75%) HGSCs. The mean elasticity score was statistically higher for the post-NACT lesions than for the pre-NACT lesions (3.13±0.57 vs. 2.04±0.51, respectively; P<0.001). The median elasticity score for the pre-NACT lesions on the four-point scale was 2, and the score for the post-NACT lesions was 4. Cases of post-NACT with scores of 3 and 4 had a higher optimal cytoreduction rate than cases with scores of 1 and 2 (93.8 vs. 25.0%, respectively; P<0.001). When the post-NACT elasticity scores of 3 and 4 were used for the prediction of optimal cytoreduction, elastography exhibited 88.2% sensitivity, 85.7% specificity, a 93.8% positive predictive value, a 75.0% negative predictive value and 87.5% accuracy. The results of the current study suggested that elastography is a sensitive tool for the evaluation of NACT in patients with HGSC and that it may aid gynecologists in choosing the optimal cytoreduction.

摘要

本研究的目的是通过超声弹性成像评估肿瘤硬度,超声弹性成像有可能提供额外信息,有助于预测高级别浆液性卵巢癌(HGSC)患者对新辅助化疗(NACT)的反应。共有32例接受NACT治疗的国际妇产科联盟III期和IV期上皮性卵巢癌患者接受了经阴道和经腹超声检查,随后进行弹性成像检查,最后进行间歇性细胞减灭术。组织病理学分析显示24例(75%)为HGSC。NACT后病变的平均弹性评分在统计学上高于NACT前病变(分别为3.13±0.57和2.04±0.51;P<0.001)。在四点量表上,NACT前病变的中位弹性评分为2分,NACT后病变的评分为4分。NACT后评分为3分和4分的病例比评分为1分和2分的病例具有更高的最佳细胞减灭率(分别为93.8%和25.0%;P<0.001)。当使用NACT后弹性评分3分和4分来预测最佳细胞减灭时,弹性成像显示出88.2%的敏感性、85.7%的特异性、93.8%的阳性预测值、75.0%的阴性预测值和87.5%的准确性。本研究结果表明,弹性成像是评估HGSC患者NACT的一种敏感工具,它可能有助于妇科医生选择最佳的细胞减灭方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8c/4156260/9fee8374d313/OL-08-04-1652-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8c/4156260/8f67d01727a6/OL-08-04-1652-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8c/4156260/9fee8374d313/OL-08-04-1652-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8c/4156260/8f67d01727a6/OL-08-04-1652-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a8c/4156260/9fee8374d313/OL-08-04-1652-g01.jpg

相似文献

1
Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma.弹性成像技术,一种用于评估高级别浆液性卵巢癌患者新辅助化疗的敏感工具。
Oncol Lett. 2014 Oct;8(4):1652-1656. doi: 10.3892/ol.2014.2346. Epub 2014 Jul 11.
2
Impact of neoadjuvant chemotherapy on somatic mutation status in high-grade serous ovarian carcinoma.新辅助化疗对高级别浆液性卵巢癌体细胞突变状态的影响。
J Ovarian Res. 2022 May 2;15(1):50. doi: 10.1186/s13048-022-00983-5.
3
Application of real-time ultrasound elastography for discrimination of low- and high-grade serous ovarian carcinoma.实时超声弹性成像在鉴别低级别浆液性卵巢癌和高级别浆液性卵巢癌中的应用。
J Ultrasound Med. 2013 Feb;32(2):257-62. doi: 10.7863/jum.2013.32.2.257.
4
Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.高级别晚期卵巢癌的初次肿瘤细胞减灭术与初次新辅助化疗:生存比较。
Radiol Oncol. 2018 Sep 11;52(3):307-319. doi: 10.2478/raon-2018-0030.
5
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer.新型生物标志物HE4在预测晚期卵巢癌新辅助化疗后最佳肿瘤细胞减灭术中的作用
Int J Gynecol Cancer. 2017 May;27(4):696-702. doi: 10.1097/IGC.0000000000000944.
6
Role of Neoadjuvant Chemotherapy (NACT) Followed by Surgical Cytoreduction in Advanced Epithelial Ovarian Cancer.新辅助化疗(NACT)后行肿瘤细胞减灭术在晚期上皮性卵巢癌中的作用
J Obstet Gynaecol India. 2012 Oct;62(5):541-5. doi: 10.1007/s13224-011-0106-8. Epub 2012 Mar 7.
7
Similar Overall Survival Using Neoadjuvant Chemotherapy or Primary Debulking Surgery in Patients Aged Over 75 Years with High-Grade Ovarian Cancer.对于 75 岁以上高级别卵巢癌患者,新辅助化疗与初次肿瘤细胞减灭术的总生存情况相似。
J Obstet Gynaecol Can. 2020 Nov;42(11):1339-1345. doi: 10.1016/j.jogc.2020.04.014. Epub 2020 May 15.
8
Multiple Cycles of Neoadjuvant Chemotherapy Associated With Poor Survival in Bulky Stage IIIC and IV Ovarian Cancer.多周期新辅助化疗与晚期IIIC期和IV期卵巢癌患者的不良生存相关。
Int J Gynecol Cancer. 2015 Oct;25(8):1398-404. doi: 10.1097/IGC.0000000000000517.
9
The chemotherapy response score is a useful histological predictor of prognosis in high-grade serous carcinoma.化疗反应评分是预测高级别浆液性癌预后的一种有用的组织学预测指标。
Histopathology. 2018 Mar;72(4):619-625. doi: 10.1111/his.13399. Epub 2017 Dec 11.
10
Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.综合性癌症中心晚期卵巢癌新辅助化疗及初次肿瘤细胞减灭术的应用情况
Gynecol Oncol. 2016 Mar;140(3):436-42. doi: 10.1016/j.ygyno.2016.01.008. Epub 2016 Jan 9.

引用本文的文献

1
STAT3 mediates ECM stiffness-dependent progression in ovarian cancer.信号转导和转录激活因子3(STAT3)介导卵巢癌中细胞外基质(ECM)硬度依赖性进展。
Mol Cell Biochem. 2025 Jan;480(1):607-620. doi: 10.1007/s11010-024-04991-5. Epub 2024 Apr 16.
2
RNA-seq reveals the diverse effects of substrate stiffness on epidermal ovarian cancer cells.RNA-seq 揭示了基质硬度对表皮卵巢癌细胞的多样化影响。
Aging (Albany NY). 2020 Oct 22;12(20):20493-20511. doi: 10.18632/aging.103906.
3
Value of shear wave elastography in the diagnosis and evaluation of cervical cancer.

本文引用的文献

1
Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography.使用超声弹性成像评价局部晚期乳腺癌新辅助化疗的反应。
Transl Oncol. 2013 Feb;6(1):17-24. doi: 10.1593/tlo.12412. Epub 2013 Feb 1.
2
Application of real-time ultrasound elastography for discrimination of low- and high-grade serous ovarian carcinoma.实时超声弹性成像在鉴别低级别浆液性卵巢癌和高级别浆液性卵巢癌中的应用。
J Ultrasound Med. 2013 Feb;32(2):257-62. doi: 10.7863/jum.2013.32.2.257.
3
New ways of assessing ovarian cancer response: metabolic imaging and beyond.
剪切波弹性成像在宫颈癌诊断及评估中的价值
Oncol Lett. 2020 Sep;20(3):2232-2238. doi: 10.3892/ol.2020.11759. Epub 2020 Jun 19.
4
Ultrasound Shear Wave Velocity Varies Across Anatomical Region in Bovine Ovaries.牛卵巢中超声剪切波速度在解剖区域上存在差异。
Tissue Eng Part A. 2020 Jul;26(13-14):720-732. doi: 10.1089/ten.tea.2020.0037. Epub 2020 Jun 30.
5
Usefulness of transabdominal real-time sonoelastography in the evaluation of ovarian lesions: preliminary results.经腹实时超声弹性成像在卵巢病变评估中的应用价值:初步结果
Br J Radiol. 2016 Sep;89(1065):20160173. doi: 10.1259/bjr.20160173. Epub 2016 Jun 28.
评估卵巢癌反应的新方法:代谢成像及其他。
Cancer Imaging. 2012 Sep 28;12(2):310-4. doi: 10.1102/1470-7330.2012.9004.
4
Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer.弹性成像评估肿瘤硬度可预测乳腺癌患者新辅助化疗的病理完全缓解。
Ann Surg Oncol. 2012 Sep;19(9):3042-9. doi: 10.1245/s10434-012-2343-1. Epub 2012 Apr 3.
5
Elastography: current status, future prospects, and making it work for you.弹性成像:现状、未来前景以及如何为您所用。
Ultrasound Q. 2011 Sep;27(3):177-86. doi: 10.1097/RUQ.0b013e31822a2138.
6
Real-time elastography for the differentiation of benign and malignant breast lesions: a meta-analysis.实时弹性成像在鉴别良恶性乳腺病变中的应用:荟萃分析。
Breast Cancer Res Treat. 2011 Nov;130(1):11-8. doi: 10.1007/s10549-011-1745-2. Epub 2011 Aug 26.
7
Serum HE4 Profile During Primary Chemotherapy of Epithelial Ovarian Cancer.上皮性卵巢癌初次化疗过程中的血清 HE4 谱。
Int J Gynecol Cancer. 2011 Dec;21(9):1573-8. doi: 10.1097/IGC.0b013e3182225509.
8
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.上皮性卵巢癌的分子发病机制和卵巢外起源——改变模式。
Hum Pathol. 2011 Jul;42(7):918-31. doi: 10.1016/j.humpath.2011.03.003.
9
Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.分子标志物和靶向治疗在卵巢癌临床试验中的作用。
Int J Gynecol Cancer. 2011 May;21(4):763-70. doi: 10.1097/IGC.0b013e31821b2669.
10
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.新辅助化疗与初始肿瘤细胞减灭术用于 IIIC 或 IV 期卵巢癌。
N Engl J Med. 2010 Sep 2;363(10):943-53. doi: 10.1056/NEJMoa0908806.